Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Solid Pseudopapillary Neoplasms (SPNs) of the Pancreas: Appraisal of Contemporary Clinicopathologic Features - Clinical Implications and Surgical Outcomes of Patients Treated and Followed at a Single Institution.

Journal of surgical oncology·2026
Same author

Overcoming resistance in advanced urothelial carcinoma: mechanisms of escape from antibody-drug conjugates and FGFR3 inhibition.

Frontiers in oncology·2025
Same author

Sensitization of tumours to immunotherapy by boosting early type-I interferon responses enables epitope spreading.

Nature biomedical engineering·2025
Same author

Ahmed ClearPath vs. Baerveldt Glaucoma Implant: A Retrospective Noninferiority Comparative Study.

Ophthalmology. Glaucoma·2023
Same author

Implementation of an opioid reduction toolkit in pancreatectomy patients significantly increases patient awareness of safe practice and decreases amount prescribed and consumed.

HPB : the official journal of the International Hepato Pancreato Biliary Association·2023
Same author

Immunotherapy reverses glioma-driven dysfunction of immune system homeostasis.

Journal for immunotherapy of cancer·2023

Related Experiment Video

Updated: Nov 23, 2025

Imaging Glioma Initiation In Vivo Through a Polished and Reinforced Thin-skull Cranial Window
09:44

Imaging Glioma Initiation In Vivo Through a Polished and Reinforced Thin-skull Cranial Window

Published on: November 20, 2012

13.4K

Brain stem gliomas and current landscape.

Brandon Wummer1, Delaney Woodworth1, Catherine Flores2

  • 1Lillian S. Wells Department of Neurosurgery, University of Florida Health Center, Gainesville, FL, 32610, USA.

Journal of Neuro-Oncology
|January 5, 2021
PubMed
Summary

Pediatric brainstem gliomas are fatal childhood cancers. New immunotherapies, including immune checkpoint inhibitors and T cell strategies, offer hope against these challenging central nervous system (CNS) malignancies.

Keywords:
Brainstem gliomaDIPGHistone mutationsTherapeutic strategies

More Related Videos

Author Spotlight: Enhanced Generation of Patient-Derived 3D Organoids for Glioblastoma and Glioma
05:45

Author Spotlight: Enhanced Generation of Patient-Derived 3D Organoids for Glioblastoma and Glioma

Published on: January 19, 2024

2.5K
Transposon Mediated Integration of Plasmid DNA into the Subventricular Zone of Neonatal Mice to Generate Novel Models of Glioblastoma
10:58

Transposon Mediated Integration of Plasmid DNA into the Subventricular Zone of Neonatal Mice to Generate Novel Models of Glioblastoma

Published on: February 22, 2015

13.2K

Related Experiment Videos

Last Updated: Nov 23, 2025

Imaging Glioma Initiation In Vivo Through a Polished and Reinforced Thin-skull Cranial Window
09:44

Imaging Glioma Initiation In Vivo Through a Polished and Reinforced Thin-skull Cranial Window

Published on: November 20, 2012

13.4K
Author Spotlight: Enhanced Generation of Patient-Derived 3D Organoids for Glioblastoma and Glioma
05:45

Author Spotlight: Enhanced Generation of Patient-Derived 3D Organoids for Glioblastoma and Glioma

Published on: January 19, 2024

2.5K
Transposon Mediated Integration of Plasmid DNA into the Subventricular Zone of Neonatal Mice to Generate Novel Models of Glioblastoma
10:58

Transposon Mediated Integration of Plasmid DNA into the Subventricular Zone of Neonatal Mice to Generate Novel Models of Glioblastoma

Published on: February 22, 2015

13.2K

Area of Science:

  • Pediatric Oncology
  • Neuro-oncology
  • Immunotherapy

Background:

  • Central nervous system (CNS) malignancies represent the leading cause of cancer-related deaths in children.
  • Brainstem gliomas are particularly aggressive and invariably fatal pediatric cancers, with limited clinical research.
  • Understanding the biological mechanisms is crucial for developing effective treatments.

Purpose of the Study:

  • To compile current knowledge on the biological mechanisms of pediatric brainstem gliomas.
  • To review and discuss available and emerging therapeutic strategies for these tumors.
  • To highlight the limitations of current standard treatments.

Main Methods:

  • Review of recent studies, including whole genome sequencing, identifying key mutations.
  • Focus on histone H3.3 mutations, particularly K27M, as a hallmark of brainstem gliomas.
  • Discussion of current standard treatments like radiation and chemotherapy and their limited efficacy.

Main Results:

  • Histone H3.3 K27M mutation is a prevalent genetic alteration in pediatric brainstem gliomas.
  • Standard therapies (radiation, chemotherapy) offer little hope for long-term survival.
  • Emerging research points to novel therapeutic avenues beyond conventional treatments.

Conclusions:

  • Immunotherapeutic strategies are being developed to target brainstem gliomas.
  • Investigational approaches include non-targeted immune checkpoint inhibitors.
  • Adoptive T cell strategies are also being explored as potential treatments for these fatal cancers.